OMVs trigger caspase activation, ultimately leading to the production of IL-1β and IL-8, proinflammatory cytokines that result in inflammation of the tumor cells [80,81] (Figure 3B), which constitutes a particularly promising attribute to exploit for therapeutic delivery. Here, IL1B is linked to neoplasm.